Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30003686HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30088900HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30076730HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30060933HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS30060934HIVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS20011880HPVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS20058749HPVENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TVIS44036219HTLV-1ENSG00000138735.16protein_codingPDE5ANoNo8654G5E9C5
O76074
TCGA Plot Options
Drug Information
GenePDE5A
DrugBank IDDB06237
Drug NameAvanafil
Target IDBE0000182
UniProt IDO76074
Regulation Typeinhibitor
PubMed IDs23372609
CitationsKedia GT, Uckert S, Assadi-Pour F, Kuczyk MA, Albrecht K: Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. Ther Adv Urol. 2013 Feb;5(1):35-41. doi: 10.1177/1756287212466282.
GroupsApproved
Direct ClassificationPyrimidinecarboxamides
SMILESCOC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL1963681